Thompson Davis & Co., Inc. Sangamo Therapeutics, Inc Transaction History

Thompson Davis & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $1,822 - $2,742	-250 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$16.7 - $26.35 $4,175 - $6,587	250 New	250 $5,000
Q4 2017 Feb 05, 2018	SELL	$11.6 - $17.35 $17,400 - $26,025	-1,500 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$8.4 - $15.0 $12,600 - $22,500	1,500	1,500 $23,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $391M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.